Generic placeholder image

Recent Patents on Biotechnology

Editor-in-Chief

ISSN (Print): 1872-2083
ISSN (Online): 2212-4012

Review Article

Medicinal Plants in the Treatment of Respiratory Diseases and their Future Aspects

Author(s): Aliya Firdaus, Mohd. Hadi Yunus, Syed Khalida Izhar and Uzma Afaq*

Volume 19, Issue 1, 2025

Published on: 24 January, 2024

Page: [2 - 18] Pages: 17

DOI: 10.2174/0118722083278561231212072408

Price: $65

Abstract

The utilization of medicinal plants in the treatment of respiratory diseases has a rich history dating back centuries. A vast body of research literature, including review articles, research papers, case studies, patents, and books, provides substantial evidence supporting the use of medicinal plants in the treatment of diseases and injuries. This study delves into the diverse range of plant species known for their therapeutic properties, with a specific focus on their applications in respiratory health. Medicinal plants have played a crucial role as a source of ingredients for medications and the synthesis of drugs. Globally, over 35,000 plant species are employed for medicinal purposes, particularly in emerging countries where traditional medicine, predominantly plant-based pharmaceuticals, serves as a primary healthcare resource. This review highlights the significance of medicinal plants, such as aloe, ginger, turmeric, tulsi, and neem, in treating a wide array of common respiratory ailments. These plants contain bioactive compounds, including tannins, alkaloids, sugars, terpenoids, steroids, and flavonoids, which have diverse therapeutic applications. Some medicinal plants, notably Echinacea purpurea and Zingiber officinale, exhibit potential for adjuvant symptomatic therapy in respiratory conditions, such as chronic obstructive pulmonary disease (COPD), bronchitis, asthma, the common cold, cough, and whooping cough. The leaves of medicinal plants like Acacia torta, Ocimum sanctum, Mentha haplocalyx, Lactuca virosa, Convolvulus pluricaulis, and Acalypha indica are commonly used to address pneumonia, bronchitis, asthma, colds, and cough. This review aims to shed light on specific medicinal plants with therapeutic value, providing valuable insights for researchers in the field of herbal medicine. These plants hold the potential to serve as novel therapeutic agents in the treatment of respiratory diseases.

[1]
Davidson-Hunt I. Ecological ethnobotany: Stumbling toward new practices and paradigms. MASA J 2000; 16: 1-13.
[2]
Chah KF, Eze CA, Emuelosi CE, Esimone CO. Antibacterial and wound healing properties of methanolic extracts of some Nigerian medicinal plants. J Ethnopharmacol 2006; 104(1-2): 164-7.
[http://dx.doi.org/10.1016/j.jep.2005.08.070] [PMID: 16226414]
[3]
Natesh S, Mohan Ram HY. An update on green medicine. J Indian Bot Soc 1999; 78: 13-23.
[4]
Aware CB, Patil DN, Suryawanshi SS, et al. Natural bioactive products as promising therapeutics: A review of natural product-based drug development. South African J Bot 2022; 151: 512-28.
[http://dx.doi.org/10.1016/j.sajb.2022.05.028]
[5]
Ravichandran S, Bhargavi KM, Rai A, Pandey T, Rajput J, Sri RMM. Medicinal plants for curing human diseases. Insight -. Chin Med 2023; 6(1): 570.
[http://dx.doi.org/10.18282/i-cm.v6i1.570]
[6]
UNESCO C. Health orientation Texts world decade for cultural development 1988-97.1996;
[7]
Khuntia A, Martorell M, Ilango K, et al. Theoretical evaluation of Cleome species’ bioactive compounds and therapeutic potential: A literature review. Biomed Pharmacother 2022; 151: 113161.
[http://dx.doi.org/10.1016/j.biopha.2022.113161] [PMID: 35644118]
[8]
Adesokan AA, Yakubu MT, Owoyele BV, Akanji MA, Soladoye AO, Lawal OK. Effect of administration of aqueous and ethanolic extracts of Enantia chlorantha stem bark on brewer’s yeast-induced pyresis in rats. Afr J Biochem Res 2008; 2: 165-9.
[9]
Alamgeer Younis W. Asif H, et al. Traditional medicinal plants used for respiratory disorders in Pakistan: A review of the ethno-medicinal and pharmacological evidence. Chin Med 2018; 13(1): 48.
[http://dx.doi.org/10.1186/s13020-018-0204-y] [PMID: 30250499]
[10]
Nascimento GGF, Locatelli J, Freitas PC, Silva GL. Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria. Braz J Microbiol 2000; 31(4): 247-56.
[http://dx.doi.org/10.1590/S1517-83822000000400003]
[11]
WHO monographs on selected medicinal plants. World Health Organization 1999.
[12]
World Health Organization WHO monographs on selected medicinal plants 2007. 3.
[13]
World Health Organization WHO monographs on selected medicinal plants 2005. 4.
[14]
Habeeb Rahuman HB, Dhandapani R, Narayanan S, et al. Medicinal plants mediated the green synthesis of silver nanoparticles and their biomedical applications. IET Nanobiotechnol 2022; 16: 115-44.
[http://dx.doi.org/10.1049/nbt2.12078]
[15]
Venugopal S, Alagesan V. Brief review of the genus diospyros montana roxb: Phytopharmacological properties. Exten Rev 2022; 2(1): 11-9.
[http://dx.doi.org/10.21467/exr.2.1.4572]
[16]
Srujana TS, Konduri RB, Rao BS. Phytochemical investigation and biological activity of leaves extract of plant Boswellia serrata. Pharma Innov 2012; 1: 22.
[17]
Rajasekharan PE, Wani SH, Eds. Conservation and utilization of threatened medicinal plants. Springer 2020.
[http://dx.doi.org/10.1007/978-3-030-39793-7]
[18]
Deeb T, Knio K, Shinwari ZK, Kreydiyyeh S, Baydoun E. Survey of medicinal plants currently used by herbalists in Lebanon. Pak J Bot 2013; 45: 543-55.
[19]
Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med 2013; 10(5): 210-29.
[http://dx.doi.org/10.4314/ajtcam.v10i5.2] [PMID: 24311829]
[20]
Riccardi B. From bioactive molecules to their nutritional effect, biodynamic interpretation between productional and functional aspects of nutrients. Recent Prog Nutr 2022; 2(4): 1-16.
[http://dx.doi.org/10.21926/rpn.2204023]
[21]
Pott DM, Osorio S, Vallarino JG. From central to specialized metabolism: An overview of some secondary compounds derived from the primary metabolism for their role in conferring nutritional and organoleptic characteristics to fruit. Front Plant Sci 2019; 10: 835.
[http://dx.doi.org/10.3389/fpls.2019.00835] [PMID: 31316537]
[22]
Jain C, Khatana S, Vijayvergia R. Bioactivity of secondary metabolites of various plants: A review. Int J Pharm Sci Res 2019; 10: 494-504.
[23]
Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotechnol 2005; 4(7): 685-8.
[http://dx.doi.org/10.5897/AJB2005.000-3127]
[24]
Cragg GM, Newman DJ. Natural product drug discovery in the next millennium. Pharm Biol 2001; 39 (Suppl. 1): 8-17.
[PMID: 21554167]
[25]
Shahidi F, Hossain A. Importance of insoluble-bound phenolics to the antioxidant potential is dictated by source material. Antioxidants 2023; 12(1): 203.
[http://dx.doi.org/10.3390/antiox12010203] [PMID: 36671065]
[26]
Maciel-Vergara G, Jensen AB, Lecocq A, Eilenberg J. Diseases in edible insect rearing systems. J Insects Food Feed 2021; 7(5): 621-38.
[http://dx.doi.org/10.3920/JIFF2021.0024]
[27]
Zeb A. Zeb phenolic antioxidants in foods: Chemistry, biochemistry and analysis. Berlin/Heidelberg, Germany: Springer 2021.
[http://dx.doi.org/10.1007/978-3-030-74768-8]
[28]
Escarpa A, Gonzalez MC. An overview of analytical chemistry of phenolic compounds in foods. Crit Rev Anal Chem 2001; 31(2): 57-139.
[http://dx.doi.org/10.1080/20014091076695]
[29]
Song Y, Chen S, Li L, Zeng Y, Hu X. The hypopigmentation mechanism of tyrosinase inhibitory peptides derived from food proteins: An overview. Molecules 2022; 27(9): 2710.
[http://dx.doi.org/10.3390/molecules27092710] [PMID: 35566061]
[30]
Obied HK. Biography of biophenols: Past, present and future. Funct Food Health Dis 2013; 3(6): 230-41.
[http://dx.doi.org/10.31989/ffhd.v3i6.51]
[31]
Wagner KH, Elmadfa I. Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes. Ann Nutr Metab 2003; 47(3-4): 95-106.
[http://dx.doi.org/10.1159/000070030] [PMID: 12743459]
[32]
Mtewa AG, Egbuna C, Rao GN, Eds. Poisonous Plants and Phytochemicals in Drug Discovery. John Wiley & Sons 2020.
[http://dx.doi.org/10.1002/9781119650034]
[33]
Molyneux RJ, Nash RJ, Asano N. Alkaloids: Chemical and biological perspectives. Elsevier 1996.
[34]
Yao C, Hao R, Pan S, Wang Y. Functional foods based on traditional Chinese medicine. In: Nutrition, Well-Being and Health. InTech 2012; pp. 179-200.
[http://dx.doi.org/10.5772/27643]
[35]
Abegaz BM, Kinfe HH. Secondary metabolites, their structural diversity, bioactivity, and ecological functions: An overview. Phys Sci Rev 2019; 4(6): 20180100.
[http://dx.doi.org/10.1515/psr-2018-0100]
[36]
Oakenfull D. Saponins in food-A review. Food Chem 1981; 7(1): 19-40.
[http://dx.doi.org/10.1016/0308-8146(81)90019-4]
[37]
Góral I, Wojciechowski K. Surface activity and foaming properties of saponin-rich plants extracts. Adv Colloid Interface Sci 2020; 279: 102145.
[http://dx.doi.org/10.1016/j.cis.2020.102145] [PMID: 32229329]
[38]
Elekofehinti OO, Iwaloye O, Olawale F, Ariyo EO. Saponins in cancer treatment: Current progress and future prospects. Pathophysiology 2021; 28(2): 250-72.
[http://dx.doi.org/10.3390/pathophysiology28020017] [PMID: 35366261]
[39]
Gurfinkel DM, Rao AV. Soyasaponins: The relationship between chemical structure and colon anticarcinogenic activity. Nutr Cancer 2003; 47(1): 24-33.
[http://dx.doi.org/10.1207/s15327914nc4701_3] [PMID: 14769534]
[40]
Kim SW, Park SK, Kang S, et al. Hypocholesterolemic property of Yucca schidigera and Quillaja saponaria extracts in human body. Arch Pharm Res 2003; 26(12): 1042-6.
[http://dx.doi.org/10.1007/BF02994756] [PMID: 14723338]
[41]
Liu J, Henkel T. Traditional Chinese medicine (TCM): Are polyphenols and saponins the key ingredients triggering biological activities? Curr Med Chem 2002; 9(15): 1483-5.
[http://dx.doi.org/10.2174/0929867023369709] [PMID: 12173978]
[42]
Kerwin S. Soy saponins and the anticancer effects of soybeans and soy-based foods. Curr Med Chem Anticancer Agents 2004; 4(3): 263-72.
[http://dx.doi.org/10.2174/1568011043352993] [PMID: 15134504]
[43]
Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013; 369(5): 448-57.
[http://dx.doi.org/10.1056/NEJMra1201534] [PMID: 23902484]
[44]
Marais BJ, Lönnroth K, Lawn SD, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: Integrating health services and control efforts. Lancet Infect Dis 2013; 13(5): 436-48.
[http://dx.doi.org/10.1016/S1473-3099(13)70015-X] [PMID: 23531392]
[45]
Bygbjerg IC. Double burden of noncommunicable and infectious diseases in developing countries. Science 2012; 337(6101): 1499-501.
[http://dx.doi.org/10.1126/science.1223466] [PMID: 22997329]
[46]
Martínez-García MA, Perpiñá-Tordera M, Román-Sánchez P, Soler-Cataluña JJ. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005; 128(2): 739-45.
[http://dx.doi.org/10.1378/chest.128.2.739] [PMID: 16100162]
[47]
Martínez-García MA, Soler-Cataluña JJ, Perpiñá-Tordera M, Román-Sánchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007; 132(5): 1565-72.
[http://dx.doi.org/10.1378/chest.07-0490] [PMID: 17998359]
[48]
Blease K, Raymon HK. Small molecule inhibitors of cell signaling: Novel future therapeutics for asthma and chronic obstructive pulmonary diseases. Curr Opin Investigat Drugs 2003; 4: 544-51.
[49]
Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: From the bench to the bedside. Proc Am Thorac Soc 2008; 5(4): 475-7.
[http://dx.doi.org/10.1513/pats.200708-126ET] [PMID: 18453358]
[50]
Larsson K. Aspects on pathophysiological mechanisms in COPD. J Intern Med 2007; 262(3): 311-40.
[http://dx.doi.org/10.1111/j.1365-2796.2007.01837.x] [PMID: 17697154]
[51]
Huang H. Plant diversity and conservation in China: Planning a strategic bioresource for a sustainable future. Bot J Linn Soc 2011; 166(3): 282-300.
[http://dx.doi.org/10.1111/j.1095-8339.2011.01157.x] [PMID: 22059249]
[52]
Kamin W, Maydannik V, Malek FA, Kieser M. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis – A randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots. Int J Clin Pharmacol Ther 2010; 48(3): 184-91.
[http://dx.doi.org/10.5414/CPP48184] [PMID: 20197012]
[53]
Liu Y. Salvia miltiorrhiza injection in the treatment of chronic obstructive pulmonary disease: A systematic review and meta-analysis. J Tradit Chin Med 2017; 37: 334-44.
[54]
Gibbs BF. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues. Int J Immunopathol Pharmacol 2009; 22(4): 919-27.
[http://dx.doi.org/10.1177/039463200902200407] [PMID: 20074455]
[55]
Ganguly D, Haque M. Intranasal administration of curcumin: A recent formulation approach to evaluate the biodistribution in the brain. Appl Biochem Biotechnol 2012; 167: 2044-52.
[56]
Shirwaikar A, Rajendran K, Bodla R, Kumar CD. Neutralization potential of Viper russelli russelli (Russell’s viper) venom by ethanol leaf extract of Acalypha indica. J Ethnopharmacol 2004; 94(2-3): 267-73.
[http://dx.doi.org/10.1016/j.jep.2004.05.010] [PMID: 15325729]
[57]
Lamabadusuriya SP, Jayantha UK. Acalypha indica induced haemolysis in G6PD deficiency. Ceylon Med J 1994; 39(1): 46-7.
[PMID: 8194149]
[58]
Keesara BR, Jat RK. Isolation and characterization of Vasicine from Adhatoda vasica (Adusa). Int J Res Develop Pharma Life Sci 2017; 6(2): 2590-6.
[http://dx.doi.org/10.21276/IJRDPL.2278-0238.2017.6(2).2590-2596]
[59]
Ko FN, Huang TF, Teng CM. Vasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta. Biochim Biophys Acta, Gen Subj 1991; 1115(1): 69-74.
[http://dx.doi.org/10.1016/0304-4165(91)90013-7] [PMID: 1659912]
[60]
Mencherini T, Cau A, Bianco G, Loggia RD, Aquino RP, Autore G. An extract of Apium graveolens var. dulce leaves: Structure of the major constituent, apiin, and its anti-inflammatory properties. J Pharm Pharmacol 2010; 59(6): 891-7.
[http://dx.doi.org/10.1211/jpp.59.6.0016] [PMID: 17637182]
[61]
Singh A, Handa SS. Hepatoprotective activity of Apium graveolens and Hygrophila auriculata against paracetamol and thioacetamide intoxication in rats. J Ethnopharmacol 1995; 49(3): 119-26.
[http://dx.doi.org/10.1016/0378-8741(95)01291-5] [PMID: 8824736]
[62]
Hamza AA, Amin A. Apium graveolens modulates sodium valproate-induced reproductive toxicity in rats. J Exp Zool Part A Ecol Genet Physiol 2007; 307A(4): 199-206.
[http://dx.doi.org/10.1002/jez.357] [PMID: 17351917]
[63]
Khare CP. Indian medicinal plants. Springer 2007.
[64]
Dieye AM, Tidjani MA, Diouf A, Bassene E, Faye B. Senegalese pharmacopoeia: Study of acute toxicity and antitussive activity of Calotropis procera AIT (Asclepiadaceae). Bull Soc Med Afr Noire Lang Fr 1993; 38(1): 69-72.
[PMID: 7882852]
[65]
Muthu C, Ayyanar M, Raja N, Ignacimuthu S. Medicinal plants used by traditional healers in Kancheepuram District of Tamil Nadu, India. J Ethnobiol Ethnomed 2006; 2(1): 43.
[http://dx.doi.org/10.1186/1746-4269-2-43] [PMID: 17026769]
[66]
Singh GD, Kaiser P, Youssouf MS, et al. Inhibition of early and late phase allergic reactions by Euphorbia hirta L. Phytother Res 2006; 20(4): 316-21.
[http://dx.doi.org/10.1002/ptr.1844] [PMID: 16557622]
[67]
Youssouf MS, Kaiser P, Tahir M, et al. Anti-anaphylactic effect of Euphorbia hirta. Fitoterapia 2007; 78(7-8): 535-9.
[http://dx.doi.org/10.1016/j.fitote.2007.06.003] [PMID: 17643865]
[68]
Sm MR, Rana S, Afm AI, et al. Antithrombotic and anti-inflammatory activities of leaf methanolic extract of Euphorbia hirta Lin. Int J Complement Altern Med 2019; 12(4): 154-62.
[http://dx.doi.org/10.15406/ijcam.2019.12.00466]
[69]
Prakash P, Gupta N. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian J Physiol Pharmacol 2005; 49(2): 125-31.
[PMID: 16170979]
[70]
Gupta SK, Prakash J, Srivastava S. Validation of traditional claim of Tulsi, Ocimum sanctum Linn. as a medicinal plant. Indian J Exp Biol 2002; 40(7): 765-73.
[71]
Walter TM. Catalogue of Siddha medicinal plants 2005.
[72]
Shilpha J, Pandian S, Largia MJV, Sohn SI, Ramesh M. Short-term storage of Solanum trilobatum L. synthetic seeds and evaluation of genetic homogeneity using SCoT markers. Plant Biotechnol Rep 2021; 15(5): 651-61.
[http://dx.doi.org/10.1007/s11816-021-00709-x]
[73]
Shahjahan M, Vani G, Shyamaladevi CS. Effect of Solanum trilobatum on the antioxidant status during diethyl nitrosamine induced and phenobarbital promoted hepatocarcinogenesis in rat. Chem Biol Interact 2005; 156(2-3): 113-23.
[http://dx.doi.org/10.1016/j.cbi.2005.08.003] [PMID: 16188247]
[74]
Shahjahan M, Sabitha KE, Jainu M, Shyamala DCS. Effect of Solanum trilobatum against carbon tetrachloride induced hepatic damage in albino rats. Indian J Med Res 2004; 120(3): 194-8.
[PMID: 15489557]
[75]
Shanmugavelu M. Noikaluku Siddha parikaram Part-I Indian medicine Homeopathy department. Government of India 2004.
[76]
Biharee A, Chaudhari L, Bhartiya S, et al. A comprehensive study on natural products and their bioactive constituents to cure respiratory diseases. Nat Prod J 2024; 14(2): e120623217879.
[http://dx.doi.org/10.2174/2210315513666230612111133]
[77]
Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytother Res 2004; 18(10): 805-9.
[http://dx.doi.org/10.1002/ptr.1555] [PMID: 15551394]
[78]
Mazzio EA, Soliman KFA. In vitro screening for the tumoricidal properties of international medicinal herbs. Phytother Res 2009; 23(3): 385-98.
[http://dx.doi.org/10.1002/ptr.2636] [PMID: 18844256]
[79]
Morrissey BM, Evans SJ. Severe bronchiectasis. Clin Rev Allergy Immunol 2003; 25(3): 233-48.
[http://dx.doi.org/10.1385/CRIAI:25:3:233] [PMID: 14716069]
[80]
Barle R, Shrivastava A, Mishra G, Agrawal S. Qualitative phytochemical study of medicinal plants of Durg District. Indian J Life Sci 2015; 5: 73-7.
[81]
Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 2006; 148(3): 245-54.
[http://dx.doi.org/10.1038/sj.bjp.0706736] [PMID: 16604091]
[82]
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2095-128.
[http://dx.doi.org/10.1016/S0140-6736(12)61728-0] [PMID: 23245604]
[83]
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020; 20(5): 533-4.
[http://dx.doi.org/10.1016/S1473-3099(20)30120-1] [PMID: 32087114]
[84]
a) Zhao J. Nutraceuticals, nutritional therapy, phytonutrients, and phytotherapy for improvement of human health: A perspective on plant biotechnology application. Recent Patents Biotechnol 2007; 1(1): 75-97.;
b) Mulin X. Plant sample sampling device for biotechnology experiment. CN2174247830 2022.

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy